Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting

• Datum:
  Úterý, 03 Únor 2026 , 13:30 - 18:00 Amsterdam time (CET)
  Středa, 04 Únor 2026 , 09:00 - 16:00 Amsterdam time (CET)
• Místo:
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

This meeting brings together the members of the Patients and Consumers Working Party (PCWP) and the Healthcare Professionals Working Party (HCPWP). Topics include:

• HTA Regulation
• Shortages
• Union list of critical medicines
• New pharmaceutical legislation
• Patient experience in evidence generation
• Information on EMA workshops

Documents

Minutes - PCWP and HCPWP joint meeting February 2026

Reference Number: EMA/025717/2026

Topics - PCWP and HCPWP joint meeting

Agenda - PCWP and HCPWP joint meeting February 2026

Draft Reference Number: EMA/384211/2025

Presentation - 1 year on: HTA in practice (S. Jouan)

Presentation - The union list of critical medicines (F. Houyez)

Presentation - Patient preferences studies (F. Houyez)

Presentation - Patient experience data in regulatory decision-making (D. Almeida, D. Umuhire, C. Jonker, K. Plueschke, R. Gonzalez-Quevedo, B. Sepodes, C. Torre)

Presentation - A new pharmaceutical framework for Europe and its patients (L. Luchianov and A. Rodiadis (EC))

Presentation - New pharma legislation (A.Nolte, M. Carr (EMA))

Presentation - From regulatory decision to health technology assessment: the new developments in Europe (M. Berntgen, N. Manent (EMA))

Presentation - HTA regulation: experience from the first year of implementation (J. Spony (EC))

Presentation - Next steps in the ECHA assessment of the PFAS universal restriction under REACH (L. Enes and R. Mezzasalma (EMA))

Presentation - Shortage mitigation and management at EU level (S. McMahon (EMA))

Presentation - Union list of critical medicines: launch of 2026 annual review (S. McMahon (EMA))

Presentation - Candidate countries observing EMA activities (K. Rugo (EMA))

Presentation - ICH E22 guideline on general considerations for patient preference studies (F. Pignatti (EMA))

Presentation - HMA-EMA Catalogues of real-world data (RWD) sources and studies (K. Deli (EMA))

Presentation - Emerging topics from PED reflection paper consultation (R. Gonzalez-Quevedo (EMA))

Presentation - Feedback from surveys in PED priority areas (C. Espinasse, F. Borrelly, F. Wilke)

Presentation - Feedback from the HMA-EMA multistakeholder workshop on artificial intelligence (L. Pinheiro (EMA))

Presentation - Information on workshop for medicines and medical devices in the cardiovascular field (I. Silva (EMA))

Presentation - EUNTC training modules

Presentation - Establishment of an expert group on vaccine confidence – call for volunteers (R. Gonzalez-Quevedo (EMA))